Product Offerings
Products:
Product Gallery:
OGRAX ARTRO
Upflora
Avert® Biolab Saúde Animal is the veterinary division of Biolab Farmacêutica, one of Brazil’s leading pharmaceutical companies. Based in Bragança Paulista, São Paulo, Avert is dedicated to animal health and wellness, with a strong focus on innovation in veterinary medicine, nutraceuticals, and dermocosmetics. The division leverages Biolab's legacy of pharmaceutical excellence to bring clinically tested, high-quality products to the veterinary sector. ## Core Business Avert operates in the animal health industry, providing pharmaceutical solutions for companion animals. The company’s business encompasses research and development, manufacturing, regulatory compliance, marketing, and distribution of medications, supplements, and veterinary dermocosmetic products. ## Product and Service Offerings - Veterinary Medicines: Prescription drugs for therapeutic treatment of common and chronic conditions in pets, including anti-inflammatories, antimicrobials, and antiparasitics. - Nutraceuticals: Supplements designed to support joint health, immunity, gastrointestinal function, and overall wellness. - Dermocosmetics: Topical products targeting dermatological conditions in pets, such as seborrhea, fungal infections, and dermatitis. - Innovation Line: Advanced formulations supported by clinical studies for complex veterinary care. ## Specialisation and Core USP Avert's unique value proposition stems from its integration with Biolab Farmacêutica, enabling: - Shared R&D resources with a pharma-grade innovation pipeline - Strict adherence to pharmaceutical manufacturing standards - Evidence-based veterinary medicine, backed by scientific publications and trials - High investment in medical education and professional training for veterinarians Their commitment to scientific excellence is highlighted by their partnerships with veterinary universities and continuous participation in national congresses and symposiums. ## Financials - Parent Company Revenue: Biolab Farmacêutica recorded R$ 2.3 billion (USD ~$460 million) in 2023. - Investment in R&D: Biolab invests over 10% of annual revenue into research and development, part of which supports the veterinary line. - Avert has experienced double-digit growth annually, in line with Brazil’s expanding pet care industry, valued at R$ 65 billion. ## Shipments and Trade Data - Avert products are primarily distributed across Brazil’s national territory, with a network of veterinary clinics, pharmacies, and pet care chains. - Some lines, under the Exzell brand, have been introduced to Latin American markets through selected partnerships. - No major export shipment volumes found through global trade databases, indicating domestic market focus. ## Target Market Avert targets: - Veterinary professionals and clinics - Pet owners seeking clinically proven treatments and supplements - Pharmacies and pet shops offering specialized therapeutic lines - Educational institutions via sponsorship of veterinary research and training ## Capabilities - State-of-the-art laboratories shared with Biolab’s pharmaceutical production - Compliance with ANVISA and MAPA regulations for animal health products - Clinical research collaborations with veterinary colleges and private clinics - Medical detailing and education teams deployed across Brazil - E-commerce ready platforms for expanding B2B and direct-to-vet sales ## Certifications and Compliance Records - ANVISA and MAPA registered facilities - GMP-certified manufacturing units - Internal pharmacovigilance and quality assurance systems - Participation in industry self-regulation and ethical marketing codes ## Customer Testimonials > “Avert has transformed our clinic’s treatment protocols. Their nutraceutical line is not only effective but also well-accepted by patients.” > — Dr. Bruno Nogueira, Veterinary Dermatologist, São Paulo > “We rely on Avert for our chronic care pet patients. Their scientific backing and professional support make all the difference.” > — Dra. Camila Oliveira, Pet Wellness Clinic, Curitiba ## Major Achievements - First Brazilian veterinary brand to apply Biolab’s pharmaceutical R&D rigor to companion animal health - Launched Exzell, a premium product line now expanding across Latin America - Developed over 60 proprietary formulations for animal health since inception - Awarded by CRMV-SP for contributions to veterinary education and research - Major presence at CBNA, CONPAVEPA, and other national veterinary conferences - Partnered with more than 20 veterinary schools for clinical trials and research support